Retina Surgery
Master Class

Associate Professor of Ophthalmology, Ain-Shams University, Cairo, Egypt.
Senior Vitreoretinal Surgery Consultant.
Co-founder of Al Mashreq Eye Center Specialized in Vitreoretinal Surgeries.
Member of the Egyptian Vitreo-Retinal Society [EGVRS] since the year 2010 and is now a member of the EGVRS scientific committee.
Fellow of the Royal college of physicians and Surgeons (Glasgow), since the year 2011
Member of The American society of retina specialists.
Head of the Trainee program for aspiring Vitreoretinal Surgeons at Al Mashreq Eye center.
Head of ROP Surgical retina and Screening team at Al Mashreq eye Center.
Performed more than 3000 anterior segment procedures, 6000 vitreoretinal surgeries and 200 Retinopathy of prematurity surgeries.
Co-authored several publications in vitreoretinal diseases and surgeries.

Ophthalmologist and Vitreoretinal Surgeon at Ain Shams University, Cairo, Egypt.
Started ophthalmology training in 2014 and completed residency in late 2017.
Began Surgical Retina & Retinopathy of Prematurity fellowship in 2018?2020, followed by the first 3D Ngenuity heads-up basic and advanced surgical retina fellowship in the MENA region (2020?2021).

Special interests include diabetic vitrectomy, advanced retinal detachment, trauma, and pediatric retina.

Since 2022, serving as co-head of the vitreoretinal training program and attending/trainer in the vitreoretinal unit at Ain Shams University, training more than 12 fellows from different countries.

Current interests include intraoperative fluorescein angiography development, small-gauge vitrectomy, and anterior segment reconstruction.

Has participated as speaker, moderator, and course instructor in more than 40 national and international conferences, with 8 national and international awards.

Alaa Din Abdin, MD, FEBO, FICO, MRCSEd (Ophth), is Associate Professor of Ophthalmology and Managing Senior Consultant. He specializes in medical and surgical vitreoretinal diseases and serves as Head of the Center for Intravitreal Injections in the Department of Ophthalmology at Saarland University Medical Center (UKS) in Homburg, Germany.
He is an active member of the European and German societies for retinal diseases. His research focuses on age-related macular degeneration and pachychoroid spectrum disease. Dr. Abdin has organized and lectured at numerous national and international conferences and scientific meetings in this field.

Arshad M. Khanani MD, MA, FASRS
Vitreo-Retinal Diseases and Surgery
Managing Partner, Director of Clinical Research, Director of Fellowship – Sierra Eye Associates
Clinical Professor – University of Nevada, Reno School of Medicine

Bilal Haj Najeeb, MD, PhD, ABOphth, FEBO, is a medical retina and neuro-ophthalmology consultant in the Department of Ophthalmology at the University of Vienna, Austria. His research focuses on multimodal imaging and artificial intelligence in retinal diseases at the Vienna Reading Center and the OPTIMA Laboratory.
He completed his medical degree and ophthalmology training at Damascus University, Syria, and earned a doctorate in Clinical Neurosciences at the Medical University of Vienna. He holds both the Arabic Board of Ophthalmology certification and the European Board of Ophthalmology certification.
Dr. Haj Najeeb also serves as a medical expert developing AI-driven solutions for retinal diseases at RetInSight and has received multiple international awards, including the ARVO-Alcon Early Career Clinical Scientific Award and the Wilhelm-Auerswald Award.

Dr. Buraa is an Ophthalmologist specializing in Uveitis, Ocular Immunology, Cornea, and Anterior Segment at Eye Surgical Hospital in Damascus, Syria. He completed his ophthalmology residency in 2015, followed by a fellowship in Uveitis and Ocular Immunology at the Massachusetts Eye Research and Surgery Institute (MERSI). He holds the CABO certification from the Arab Board of Health Specializations and the FICO from the International Council of Ophthalmology. He has multiple publications, international presentations, and is an active member of the American Academy of Ophthalmology and the Ocular Immunology and Uveitis Foundation.

Dr. Tawfik, MD, is an Associate Professor of Ophthalmology at Ain Shams University and a Consultant in Ophthalmic Genetics and Medical Retina. She completed an ICO fellowship in Ophthalmic Genetics at Ludwig-Maximilian University in Munich, Germany.
She established the first Ophthalmic Genetics Clinic in 2022, serving patients with inherited retinal diseases, hereditary optic neuropathies, and other genetic eye disorders from across Egypt.
She is a member of EURETINA, ISCEV, and ISGEDR, with expertise in medical retina, electrophysiology of vision, and genetic eye diseases.

Dina Baddar, MD, PhD, FRCS (Glasgow), is a Medical Retina and Uveitis Consultant in Cairo and Alexandria, and a tenured faculty member at the Research Institute of Ophthalmology (RIO) in Giza. With over 10 years of clinical experience, she is an appointed consultant of ocular inflammation for the Egyptian Health Insurance Organization (HIO) and an elected Board Member of the Egyptian Vitreoretinal Society (EGVRS).
In 2024, she co-founded the Middle East and Africa Council of Ophthalmology Uveitis Society (MEACOUS) with a group of regional uveitis experts.
Her expertise includes retinal imaging and diagnostics, retinal therapeutics, uveitis, scleritis, autoimmune ocular surface diseases, and inherited retinal dystrophies.

He is a Senior Vitreoretinal Consultant at the Jordanian Hospital in Amman. Dr. Fayyad graduated from La Sapienza University in Rome in 1976 and completed his ophthalmology residency there from 1977 to 1981 with honors. He later completed a two-year clinical retina fellowship at the University of Ottawa in Canada.
He has served at the Jordanian Ministry of Health hospitals, the King Hussein Medical Center, and the Jordan University Hospital. He is an examiner for the Jordanian Board of Ophthalmology and is actively involved in training ophthalmologists in vitreoretinal surgery.

Jay Chhablani, MD, is a Professor of Ophthalmology and Vitreoretinal Surgeon at the University of Pittsburgh, USA. He serves as the Director of Clinical Research at the UPMC Vision Institute and is the founder of the Choroid Analysis and Research (CAR) Lab, which focuses on computational and biological research of the choroid.
He has published more than 650 peer-reviewed articles, authored and edited multiple books, and is a member of the Macula Society and the Gonin Club. He has delivered over 200 invited lectures and has been invited as a visiting professor at numerous universities worldwide.

A/Prof Kelvin Teo, MD, is a Medical Retina specialist with a primary clinical and research focus on retinal angiogenic diseases, particularly age-related macular degeneration (AMD). His work explores novel therapeutic strategies, including pharmacologic and biologic interventions targeting disease pathophysiology.
He is actively involved in retinal imaging innovation and the development of advanced imaging modalities to enhance early detection, monitor disease progression, and assess treatment response.
With more than 100 peer-reviewed publications, his work contributes significantly to the evolving understanding of retinal disease mechanisms and therapeutic advancements. His engagement in clinical trials, translational research, and professional education reflects his commitment to bridging laboratory discoveries with real-world clinical applications. His work supports precision medicine approaches and advances patient-centered retinal care.

Mr. Luke Nicholson, MD, is a consultant ophthalmologist and medical retina specialist at Moorfields Eye Hospital in London, where he serves as Director of the Medical Retina Service. He has completed multiple clinical and research fellowships in medical retina and uveitis at Moorfields.
He has published extensively on retinal vascular diseases, co-authored the Royal College of Ophthalmologists (UK) Retinal Vein Occlusion Guidelines, and is the chief investigator for national and international clinical studies.

Dr. Magdy Moussa, MD, is a Professor of Ophthalmology at the Faculty of Medicine, Tanta University, Egypt. He graduated from the same institution and has presented extensively in the diagnosis and management of retinal diseases.
His presentations span national meetings such as the Egyptian Vitreoretinal Society (EGVRS) and the Cairo Retina Meeting (CRM), as well as major international conferences including the World Ophthalmology Congress (WOC), Royal College of Ophthalmologists (RCOphth), Middle East African Council of Ophthalmology (MEACO), Jordanian Ophthalmological Society (JOS), Thessaloniki Vitreoretinal School (TVRS) as an instructor, Afro-Asian Council of Ophthalmology (AACO), and the American Academy of Ophthalmology (AAO) as a course instructor.

Mohamed Tawfik, MD, FRCS (Ed), is a Vitreoretinal Consultant and CEO of El Ferdaws Eye Center. He also serves as a Vitreoretinal Consultant at El Mashreq Eye Center in Egypt.

Omar Mahroo, MD, PhD, FRCOphth, is a consultant ophthalmologist and inherited retinal disease specialist at Moorfields Eye Hospital and St Thomas? Hospital in London. He is also Professor of Retinal Neuroscience at University College London.
He completed his medical degree and PhD at the University of Cambridge, followed by post-doctoral work at the Australian National University. After ophthalmology specialist training in London, he became a Fellow of the Royal College of Ophthalmologists in 2012.
He has published more than 160 papers and several book chapters, and has received major grant funding including a ?1.1 million Wellcome Trust award. His recognitions include the Macular Society ?Rising Star of the Year? (2019) and awards for teaching excellence and public engagement (2020).
In 2023, he was elected Fellow of the Royal Society of Biology and Fellow of the Physiological Society, and in 2025 he became Director of Standards for the International Society for Clinical Electrophysiology of Vision.

Dr. Hamam, MD, is an Associate Professor of Ophthalmology at the American University of Beirut. She serves as Director of both the residency training program and the medical retina fellowship program. In 2008, she established the first uveitis specialty referral service in Lebanon.
She is an active member of the American Uveitis Society, an ambassador and active member of the International Uveitis Study Group, and a member of the MEACO Uveitis Society. She has organized and lectured on uveitis at national and international conferences.
Dr. Hamam is involved in multiple research projects focused on ocular inflammatory and infectious diseases and has published more than 40 scientific papers on regionally and internationally relevant topics.

Mr. Sami Habal, MD, is a Consultant Ophthalmologist and Vitreoretinal Surgeon at King?s College Hospital London with over 20 years of ophthalmic experience. He has a special interest in diabetic retinopathy and is a senior expert in managing cataract complications, with a strong record of surgical outcomes.
He has published in peer-reviewed ophthalmology journals and is a regular speaker at national and international conferences. He is dedicated to training ophthalmology residents and vitreoretinal fellows in the UK.
Mr. Habal is a member of the British and Eire Association of Vitreoretinal Surgeons (BEAVRS), among other professional affiliations, and serves as a clinical supervisor, appraiser, and trainee assessor at the Royal College of Ophthalmologists in London.

SriniVas R. Sadda, MD, is the Director of Artificial Intelligence & Imaging Research at the Doheny Eye Institute and Professor of Ophthalmology at the University of California?Los Angeles (UCLA) Geffen School of Medicine. He is the immediate past President of the Doheny Eye Institute.
He received his MD from Johns Hopkins University, where he also completed his ophthalmology residency and fellowships in neuro-ophthalmology and medical retina at the Wilmer Eye Institute.

Dr. Sadda?s research focuses on retinal image analysis, advanced retinal imaging technologies, and clinical trial endpoint design. He has authored more than 725 peer-reviewed publications, 20 book chapters, and delivered over 500 presentations worldwide.
He is Editor-in-Chief of the 7th edition of Ryan?s Retina, serves as an Editor-in-Chief of Graefe?s Archive for Clinical and Experimental Ophthalmology, and is on the editorial boards of Ophthalmic Surgery, Lasers & Imaging, Retina, Ophthalmology Retina, Ophthalmology Science, and Ophthalmology.

His awards include the Research to Prevent Blindness Physician-Scientist Award, Senior Honor Award from the American Society of Retina Specialists, Achievement and Secretariat Awards from the American Academy of Ophthalmology, the Macula Society?s Young Investigator Award, ASRS Young Investigator Award, APAO Achievement Award, the Paul Henkind Lecture and Award, the Euretina Lecture, the Retina Society Charles Schepens Lecture, and the VRSI Nataraja Pillai Oration.
His research is continuously funded by the National Institutes of Health, including two active R01 grants from the National Eye Institute, and he has been listed among the Best Doctors of America for multiple consecutive years.

Tamer Mahmoud, MD, PhD, is a Professor of Ophthalmology at Oakland University William Beaumont School of Medicine and Director of the Vitreoretinal Fellowship at Associated Retinal Consultants. He previously served as Director of the vitreoretinal fellowship at Duke University and the Kresge Eye Institute.

He has pioneered multiple surgical innovations, including the use of subretinal air for submacular hemorrhage displacement (2013) and the first human autologous retinal transplantation (2015). He introduced chandelier buckles in the United States and developed the ILM retracting door technique for macular holes (2017).
In 2019, he created the nano subretinal gateway device to access the subretinal space without PPV?enabling displacement of subretinal hemorrhage, delivery of gene therapy and drugs, removal of PFO, and tumor biopsy.
In 2022, he introduced the concept of using epiretinal membrane to close large macular holes, and in 2023 performed the first combined amniotic and autologous retinal transplant for large refractory myopic macular holes with atrophy.

In recent years, Dr. Mahmoud has led global collaborative studies focused on developing treatment guidelines for challenging macular holes using the surgical techniques he helped advance.

His awards include the ASRS Presidential Honor Award, the Robert A. Machemer Research Award (Duke Eye Center), the Distinguished Teacher of the Year Award (Kresge Eye Institute), and the Golden Globe Award for resident education (Duke Eye Center), among many others.

Yousef A. Fouad, MD, FRCS (Glasg.), is a retina specialist and lecturer of ophthalmology at Ain Shams University Hospitals. He is a former visiting fellow at the Stein Eye Institute, University of California, Los Angeles, where he trained in retinal disorders and ophthalmic genetics.
He specializes in retinal imaging and macular diseases and has published more than 50 peer-reviewed journal articles and 3 book chapters. He also serves as an editor and reviewer for several reputable journals in the field.

Mr. Elhousseini, MD, MSc, FRCOphth, is a specialist in surgical and medical retina. After completing his medical degree in 2006 and a Master?s in Ophthalmology, he moved to the UK in 2013 and became a Fellow of the Royal College of Ophthalmologists.
He is currently a consultant specialist within the NHS, Lead of the Retina Clinical Pathway Group, and Clinical Lead for the North Central London Diabetic Eye Screening Programme.
He has supervised many trainees and fellows, serves as Deputy Academic Lead, and is an examiner for medical students at University College London (UCL).
Mr. Elhousseini conducts multiple research projects at the Royal Free Hospital, has co-authored several publications in ophthalmology and vitreoretinal surgery, and has presented at national and international meetings.